EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Neglected Tropical Diseases: Current Treatment Challenges and Future Therapeutic Potentials

Elhassan Hussein Eltom, Bandar Theyab Alenezi, Mohamed Soliman, Muhammad Jan, Amro Soliman

Prospects in Pharmaceutical Sciences · 05.04.2025 · 23 (2) · 1-9

DOI: 10.56782/pps.295 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Prospects in Pharmaceutical Sciences, online erschienen am 05.04.2025. Verfasst von Elhassan Hussein Eltom und 4 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neglected tropical diseases (NTDs) predominantly affect developing countries. Human African trypanosomiasis, leishmaniasis, Chagas disease, and malaria are protozoan infections that are endemic in developing countries and for which new drugs are desperately needed. Gaining better control of these diseases requires discovering and developing safe, effective, and affordable new drugs for the populations at risk. Unfortunately, incentives for the research and development of new medicine to combat NTDs are currently insufficient. This paper examines recent efforts to increase R&D investments in the development of new anti-parasitic drugs and provides an overview of the most recent and promising compounds at different development stages for each pathogen. Additionally, information on the development of novel formulations combining existing drugs and delivery systems that can improve therapeutic outcomes as well as recent advances in drug discovery, obstacles to developing new chemical entities (NCEs), and the role of public-private partnerships (PPPs) are discussed. In conclusion, drug discovery for neglected diseases entails a larger challenge of demonstrating translational readiness at an early stage. Classification systems can help identify gaps and focus research and development efforts on candidates with the highest likelihood of becoming clinical options. To overcome funding shortages and reduce the incubation time for promising drug discovery initiatives, it is necessary to harness the power of collaborative networks and use innovative funding models.

Zitieren

APA

Eltom, E. H., Alenezi, B. T., Soliman, M., Jan, M., & Soliman, A. (2025). Neglected Tropical Diseases: Current Treatment Challenges and Future Therapeutic Potentials. Prospects in Pharmaceutical Sciences, 23(2), 1-9. https://doi.org/10.56782/pps.295

Vancouver

Eltom EH, Alenezi BT, Soliman M, Jan M, Soliman A. Neglected Tropical Diseases: Current Treatment Challenges and Future Therapeutic Potentials. Prospects in Pharmaceutical Sciences. 2025;23(2):1-9. doi:10.56782/pps.295

BibTeX
@article{Eltom2025,
  author = {Eltom, Elhassan Hussein and Alenezi, Bandar Theyab and Soliman, Mohamed and Jan, Muhammad and Soliman, Amro},
  title = {Neglected Tropical Diseases: Current Treatment Challenges and Future Therapeutic Potentials},
  journal = {Prospects in Pharmaceutical Sciences},
  year = {2025},
  volume = {23},
  number = {2},
  pages = {1--9},
  doi = {10.56782/pps.295}
}
Kostenlos starten →